Ambu grows single-use endoscope sales by 25%, maintains full-year outlook
On Tuesday morning, the medtech company presented its financial statements for the period October to December 2023.
In the first three months of the financial year, the medtech company Ambu reported organic revenue growth of 14% to DKK 1254 million compared to DKK 1132 million in the same quarter a year ago.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
